Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 550 E Swedesford Rd, Suite 400 WAYNE PA 19087 |
Tel: | N/A |
Website: | https://www.teleflex.com |
IR: | See website |
Key People | ||
Liam J. Kelly Chairman of the Board, President, Chief Executive Officer | Thomas E. Powell Chief Financial Officer, Executive Vice President | Daniel V. Logue Corporate Vice President, General Counsel and Secretary |
Cameron P. Hicks Corporate Vice President - Human Resources and Communications | Jay White Corporate Vice President and President, Global Commercial | James Winters Corporate Vice President - Manufacturing and Supply Chain |
Business Overview |
Teleflex Incorporated is a global provider of medical technology products. The Company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The Company has four segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM (Original Equipment Manufacturer and Development Services). OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. Its OEM division includes the TFX Medical OEM, TFX OEM, Deknatel and HPC Medical brands, provides custom extrusions, micro-diameter film-cast tubing, diagnostic and interventional catheters, balloons and balloon catheters, film-insulated fine wire, coated mandrel wire, conductors, sheath/dilator introducers, and others. Its other brands include Arrow, LMA, Pilling, QuikClot, Rusch, UroLift, Weck and Barrigel. |
Financial Overview |
For the fiscal year ended 31 December 2023, Teleflex Inc revenues increased 7% to $2.97B. Net income before extraordinary items decreased 1% to $357.6M. Revenues reflect Americas segment increase of 4% to $1.72B, OEM segment increase of 20% to $326M, Asia segment increase of 13% to $346.9M, United States segment increase of 5% to $1.88B, Europe segment increase of 7% to $665.2M, Asia Pacific segment increase of 14% to $307.5M. |
Employees: | 14,500 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $12,235M as of Dec 31, 2023 |
Annual revenue (TTM): | $2,974M as of Dec 31, 2023 |
EBITDA (TTM): | $804.83M as of Dec 31, 2023 |
Net annual income (TTM): | $357.57M as of Dec 31, 2023 |
Free cash flow (TTM): | $355.30M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $1,592M as of Dec 31, 2023 |
Shares outstanding: | 47,056,482 as of Feb 20, 2024 |
Index Membership: | S&P 500 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |